Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Israel Englander is the founder and CEO of Millennium Management, a leading hedge fund in the USA.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Israel Englander is Chairman and Chief Executive Officer of Millennium
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Mamba Exploration's Mike Dunbar Discusses Sulphide Discovery at Black Hills Priority Target | Mike Dunbar , CEO ,Mamba Exploration.
00:10:00
"The Path to True Wealth: Time-Tested Strategies Revealed! | Charlie Horonzy, CFP®, CPA at Focused Up Financial, LLC"
00:10:00
CEO Bill Bosway Talks Growth and Milestones at Gibraltar Industries | BILL BOSWAY - Chairman of the Board of Directors, and CEO of Gibraltar Industries
00:10:00
Revolutionizing Financial Planning: Insights from Laura Ryan, CFP
00:10:00
Natural Resources: Transforming from Gold Explorer to Producer in Western Australia
00:10:00
Integrity Partners with Lion Street to Expand Life and Wealth Solutions
00:10:00
David Azerad discusses his contribution to the paleoconservative anthology and his relationship with Paul Gottfried.|David Azerrad,Professor,Hillsdale College
00:10:00
FBN, a unit of FOX News Media with bureaus in Chicago, discusses Rumble's view that Twitter caused 'the worst, most egregious' implications.
00:10:00
ACCO Brands CEO Boris Elisman on Navigating Supply Chain Challenges and Strategic Growth | Boris Elisman, CEO , ACCO Brand.
00:10:00
New Core Gold CEO Luke Alexander Discusses Robust Economics and Growth Potential of EN Project in Ghana
00:10:00
Graham is poised to become only the 4th CEO in Softcat's history later in 2023.
00:00:00
Polarean Imaging receives "clear indication of belief in the company" from major shareholder - Dr. Christopher von Jako Chief Executive Officer, Polarean Imaging